JBCHEPHARM Historical Balance Sheet

JBCHEPHARM

1,735 10.35 0.60%

Trend analysis of JB Chemicals Pharmaceuticals balance sheet accounts such as Other Current Liabilities of 1 B or Total Current Liabilities of 9.1 B provides information on JB Chemicals' total assets, liabilities, and equity, which is the actual value of JB Chemicals Pharmac to its prevalent stockholders. By breaking down trends over time using JB Chemicals balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining JB Chemicals Pharmac latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether JB Chemicals Pharmac is a good buy for the upcoming year.

JB Chemicals Inventory

5.28 Billion

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in JB Chemicals Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

About JBCHEPHARM Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of JB Chemicals Pharmac at a specified time, usually calculated after every quarter, six months, or one year. JB Chemicals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of JB Chemicals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which JBCHEPHARM currently owns. An asset can also be divided into two categories, current and non-current.

JB Chemicals Balance Sheet Chart

As of now, JB Chemicals' Total Stockholder Equity is increasing as compared to previous years. The JB Chemicals' current Net Debt is estimated to increase to about 3 B, while Other Current Liabilities is projected to decrease to under 1 B.

Total Assets Short Long Term Debt Total Total Current Liabilities Total Stockholder Equity Accounts Payable Liabilities And Stockholders Equity

Add Fundamental

Total Assets

Total assets refers to the total amount of JB Chemicals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in JB Chemicals Pharmac books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on JB Chemicals balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of JB Chemicals Pharmaceuticals are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Accounts Payable

An accounting item on the balance sheet that represents JB Chemicals obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of JB Chemicals Pharmac are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Liabilities And Stockholders Equity

The total of all liabilities and equity in the company, which should equal the company's total assets according to the accounting equation.

Most accounts from JB Chemicals' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into JB Chemicals Pharmac current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in JB Chemicals Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	545.6M	5.7B	3.8B	4.0B
Total Assets	26.1B	35.5B	39.9B	41.9B

Short Long Term Debt Total Total Assets

JB Chemicals balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Good Will	Intangible Assets	Current Deferred Revenue
Total Assets		0.77	-0.01	0.91	0.99	0.59	0.71	0.97	0.97	0.2	0.98	-0.22	0.05	0.74	0.66	-0.01	0.61	0.97	0.18	-0.37	0.94	0.74	-0.76	0.56	0.94	-0.31
Short Long Term Debt Total	0.77		-0.22	0.77	0.69	0.21	0.94	0.69	0.67	0.22	0.82	-0.11	-0.09	0.53	0.42	-0.16	0.84	0.65	-0.09	-0.44	0.92	0.46	-0.52	0.25	0.87	-0.32
Other Current Liab	-0.01	-0.22		-0.03	0.01	-0.17	-0.23	0.01	0.02	0.01	-0.11	0.43	0.34	-0.02	0.01	0.34	-0.12	-0.03	-0.2	0.06	-0.07	0.15	-0.04	-0.36	-0.01	0.12
Total Current Liabilities	0.91	0.77	-0.03		0.88	0.43	0.72	0.82	0.9	0.11	0.89	-0.04	0.11	0.59	0.48	0.08	0.43	0.84	0.16	-0.15	0.94	0.62	-0.66	0.37	0.86	-0.24
Total Stockholder Equity	0.99	0.69	0.01	0.88		0.64	0.62	0.98	0.97	0.2	0.96	-0.25	0.05	0.75	0.68	-0.01	0.55	0.98	0.22	-0.35	0.89	0.76	-0.77	0.61	0.9	-0.31
Property Plant And Equipment Net	0.59	0.21	-0.17	0.43	0.64		0.25	0.62	0.59	-0.08	0.58	-0.23	0.06	0.64	0.59	0.09	0.26	0.67	0.42	-0.22	0.41	0.66	-0.28	0.94	0.35	0.19
Net Debt	0.71	0.94	-0.23	0.72	0.62	0.25		0.63	0.62	-0.11	0.76	-0.02	-0.16	0.51	0.38	-0.13	0.8	0.61	-0.02	-0.45	0.87	0.41	-0.47	0.29	0.78	-0.14
Retained Earnings	0.97	0.69	0.01	0.82	0.98	0.62	0.63		0.98	0.18	0.95	-0.33	-0.03	0.81	0.77	-0.08	0.63	0.99	0.22	-0.53	0.87	0.74	-0.84	0.64	0.9	-0.36
Accounts Payable	0.97	0.67	0.02	0.9	0.97	0.59	0.62	0.98		0.13	0.94	-0.27	0.0	0.78	0.72	-0.04	0.5	0.98	0.24	-0.43	0.89	0.71	-0.84	0.59	0.9	-0.36
Cash	0.2	0.22	0.01	0.11	0.2	-0.08	-0.11	0.18	0.13		0.19	-0.25	0.19	0.13	0.15	-0.11	0.22	0.13	-0.2	-0.02	0.17	0.21	-0.07	-0.09	0.28	-0.51
Non Current Assets Total	0.98	0.82	-0.11	0.89	0.96	0.58	0.76	0.95	0.94	0.19		-0.28	-0.14	0.77	0.62	-0.2	0.66	0.94	0.15	-0.4	0.94	0.64	-0.73	0.59	0.96	-0.35
Non Currrent Assets Other	-0.22	-0.11	0.43	-0.04	-0.25	-0.23	-0.02	-0.33	-0.27	-0.25	-0.28		0.39	-0.4	-0.34	0.47	-0.2	-0.29	-0.01	0.4	-0.11	-0.03	0.36	-0.43	-0.22	0.52
Cash And Short Term Investments	0.05	-0.09	0.34	0.11	0.05	0.06	-0.16	-0.03	0.0	0.19	-0.14	0.39		-0.25	0.03	0.95	-0.14	-0.02	-0.14	0.28	0.02	0.44	0.12	-0.16	-0.15	0.21
Net Receivables	0.74	0.53	-0.02	0.59	0.75	0.64	0.51	0.81	0.78	0.13	0.77	-0.4	-0.25		0.79	-0.29	0.6	0.82	0.29	-0.6	0.67	0.7	-0.55	0.71	0.72	-0.2
Common Stock Shares Outstanding	0.66	0.42	0.01	0.48	0.68	0.59	0.38	0.77	0.72	0.15	0.62	-0.34	0.03	0.79		-0.01	0.54	0.77	0.48	-0.71	0.57	0.77	-0.58	0.61	0.58	-0.14
Short Term Investments	-0.01	-0.16	0.34	0.08	-0.01	0.09	-0.13	-0.08	-0.04	-0.11	-0.2	0.47	0.95	-0.29	-0.01		-0.21	-0.06	-0.08	0.29	-0.03	0.38	0.15	-0.13	-0.23	0.37
Non Current Liabilities Total	0.61	0.84	-0.12	0.43	0.55	0.26	0.8	0.63	0.5	0.22	0.66	-0.2	-0.14	0.6	0.54	-0.21		0.55	-0.12	-0.71	0.71	0.5	-0.4	0.33	0.72	-0.21
Inventory	0.97	0.65	-0.03	0.84	0.98	0.67	0.61	0.99	0.98	0.13	0.94	-0.29	-0.02	0.82	0.77	-0.06	0.55		0.33	-0.47	0.86	0.75	-0.82	0.68	0.87	-0.29
Other Current Assets	0.18	-0.09	-0.2	0.16	0.22	0.42	-0.02	0.22	0.24	-0.2	0.15	-0.01	-0.14	0.29	0.48	-0.08	-0.12	0.33		-0.04	0.07	0.27	-0.14	0.41	0.04	0.33
Other Stockholder Equity	-0.37	-0.44	0.06	-0.15	-0.35	-0.22	-0.45	-0.53	-0.43	-0.02	-0.4	0.4	0.28	-0.6	-0.71	0.29	-0.71	-0.47	-0.04		-0.39	-0.31	0.57	-0.39	-0.44	0.25
Total Liab	0.94	0.92	-0.07	0.94	0.89	0.41	0.87	0.87	0.89	0.17	0.94	-0.11	0.02	0.67	0.57	-0.03	0.71	0.86	0.07	-0.39		0.64	-0.69	0.4	0.95	-0.29
Total Current Assets	0.74	0.46	0.15	0.62	0.76	0.66	0.41	0.74	0.71	0.21	0.64	-0.03	0.44	0.7	0.77	0.38	0.5	0.75	0.27	-0.31	0.64		-0.36	0.55	0.59	0.01
Common Stock	-0.76	-0.52	-0.04	-0.66	-0.77	-0.28	-0.47	-0.84	-0.84	-0.07	-0.73	0.36	0.12	-0.55	-0.58	0.15	-0.4	-0.82	-0.14	0.57	-0.69	-0.36		-0.38	-0.73	0.45
Good Will	0.56	0.25	-0.36	0.37	0.61	0.94	0.29	0.64	0.59	-0.09	0.59	-0.43	-0.16	0.71	0.61	-0.13	0.33	0.68	0.41	-0.39	0.4	0.55	-0.38		0.37	0.02
Intangible Assets	0.94	0.87	-0.01	0.86	0.9	0.35	0.78	0.9	0.9	0.28	0.96	-0.22	-0.15	0.72	0.58	-0.23	0.72	0.87	0.04	-0.44	0.95	0.59	-0.73	0.37		-0.46
Current Deferred Revenue	-0.31	-0.32	0.12	-0.24	-0.31	0.19	-0.14	-0.36	-0.36	-0.51	-0.35	0.52	0.21	-0.2	-0.14	0.37	-0.21	-0.29	0.33	0.25	-0.29	0.01	0.45	0.02	-0.46

Click cells to compare fundamentals

JB Chemicals Account Relationship Matchups

JB Chemicals balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	18.1B	22.4B	26.1B	35.5B	39.9B	41.9B
Short Long Term Debt Total	382.2M	449.9M	545.6M	5.7B	3.8B	4.0B
Other Current Liab	911.3M	1.1B	1.1B	236.5M	1.4B	1.0B
Total Current Liabilities	3.1B	3.5B	3.8B	5.5B	8.7B	9.1B
Total Stockholder Equity	14.4B	18.1B	21.3B	24.8B	29.2B	30.7B
Property Plant And Equipment Net	5.8B	5.7B	5.7B	5.8B	6.3B	4.5B
Net Debt	92.1M	163.0M	(19.9M)	5.0B	2.9B	3.0B
Retained Earnings	12.3B	15.8B	18.4B	22.8B	25.1B	26.4B
Accounts Payable	1.7B	1.9B	2.2B	2.4B	3.6B	3.7B
Cash	290.1M	286.9M	565.4M	769.3M	882.2M	531.0M
Non Current Assets Total	7.4B	6.9B	13.3B	20.3B	21.4B	22.5B
Cash And Short Term Investments	3.6B	6.9B	566.5M	2.9B	4.6B	3.3B
Net Receivables	3.6B	3.9B	6.2B	5.8B	7.0B	3.8B
Common Stock Shares Outstanding	159.1M	154.6M	154.7M	156.6M	158.6M	113.5M
Short Term Investments	3.3B	6.6B	1.1M	2.2B	3.7B	2.8B
Liabilities And Stockholders Equity	18.1B	22.4B	26.1B	35.5B	39.9B	41.9B
Non Current Liabilities Total	627.2M	794.1M	850.7M	5.2B	2.0B	1.3B
Inventory	2.7B	3.5B	4.1B	4.3B	5.0B	5.3B
Other Current Assets	4.4B	5.1B	8.1B	2.3B	1.9B	2.6B
Other Stockholder Equity	507.7M	2.1B	2.8B	(807.1M)	2.7B	3.4B
Total Liab	3.8B	4.2B	4.7B	10.7B	10.7B	11.2B
Total Current Assets	10.7B	15.5B	12.7B	15.3B	18.5B	10.3B
Accumulated Other Comprehensive Income	(5.2B)	1.6B	2.2B	2.7B	1.3B	1.3B
Common Stock	167.1M	160.5M	154.6M	154.8M	155.2M	131.5M
Intangible Assets	300.9M	321.1M	6.7B	13.2B	13.9B	14.6B
Current Deferred Revenue	1.5B	1.1B	1.2B	1.2B	129.9M	123.4M
Short Term Debt	344.5M	398.5M	339.4M	1.7B	3.4B	3.6B
Other Liab	648.4M	680.7M	742.7M	644.6M	741.2M	536.5M
Net Tangible Assets	14.0B	13.5B	17.2B	14.1B	16.2B	14.2B
Other Assets	105.3M	133.8M	241.6M	123.8M	142.4M	130.7M
Short Long Term Debt	320.4M	326.4M	263.2M	1.7B	3.3B	3.5B
Property Plant Equipment	5.8B	5.7B	5.7B	5.8B	6.6B	5.8B
Long Term Debt Total	12.3M	51.4M	206.2M	4.0B	4.6B	4.8B
Non Current Liabilities Other	59.7M	49.3M	31.7M	25M	17M	28.0M
Net Invested Capital	14.7B	18.4B	21.6B	30.3B	32.8B	23.2B
Cash And Equivalents	290.1M	33.9M	18.2M	269.1M	309.5M	325.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Other Information on Investing in JBCHEPHARM Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

JBCHEPHARM Historical Balance Sheet

JB Chemicals Inventory

5.28 Billion

About JBCHEPHARM Balance Sheet Analysis

JB Chemicals Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

Accounts Payable

Liabilities And Stockholders Equity

JB Chemicals balance sheet Correlations

JB Chemicals Account Relationship Matchups

High Positive Relationship

High Negative Relationship

JB Chemicals balance sheet Accounts

Also Currently Popular

Other Information on Investing in JBCHEPHARM Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 0.99	Total Assets
Inventory	+ 0.99	Retained Earnings
Non Current Assets Total	+ 0.98	Total Assets
Retained Earnings	+ 0.98	Total Stockholder Equity
Inventory	+ 0.98	Total Stockholder Equity
Accounts Payable	+ 0.98	Retained Earnings

Common Stock	- 0.84	Accounts Payable
Common Stock	- 0.84	Retained Earnings
Common Stock	- 0.82	Inventory
Common Stock	- 0.77	Total Stockholder Equity
Common Stock	- 0.76	Total Assets
Intangible Assets	- 0.73	Common Stock